The funds described herein are open to “accredited investors” only, through an offering made in accordance with Regulation D, Rule 506(c) of the Securities Act of 1933, as amended. In purchasing securities through a 506(c) offering, we are obligated to verify any participating investor’s status as an “accredited investor” in accordance with Rule 501 of Regulation D. Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. We do not make any representations as to the accuracy or completeness of the information contained on this website and undertake no obligation to update the information. Past performance is not an indicator of any future results. All investments contain risk and may lose value. This does not constitute an offer to sell or a solicitation of interest to purchase any securities or investment advisory services in any country or jurisdiction in which such offer or solicitation is not permitted by law.

Shockwave Therapy – Dr. David C. Karli

In this Show

Shockwave therapy has been developed for medical applications over a number of years. In this post David reviews a new type of sound based energy which is being applied to medical indications for anti-inflammation effects as well as stimulating healing within tissues. Interesting new technology that is under investigation that may have traction in the medical/biotech market space.

Get in contact with David C. Karli through his website, LinkedIn and learn more about Greyledge Technologies here:

(Visited 26 times, 1 visits today)